We employ some 2,800 people in R&D at Alderley Park (out of a total of 4,500 employees at this site) in a range of disciplines including chemistry, bioscience, pharmacology, genetics, clinical research and regulatory.
Alderley Park already has an enviable record in the history of pharmaceutical innovation, being involved in the discovery, research and development of a number of treatments across various therapy areas.
Not signed in
Page tools
Share price
- London
-
26.95 GBP - New York
-
44.82 USD - Stockholm
-
310.10 SEK
At 21-Nov-2009 03:08 GMT
Detailed share priceIntroduction to AstraZeneca
Our responsibility
We continue to communicate openly on a range of issues, including:
